Genetic Sequence Variants in <i>TLR4</i>, <i>MBL</i> or <i>IL-1</i> Receptor Antagonist is not Associated to Increased Risk for Febrile Neutropenia in Children with ALL

Sequence variants in genes involved in the immune system have previously been linked to neutropenia as well as infections in cancer patients. Sequence variants in genes coding for <i>TLR4</i>, <i>MBL</i>, and <i>IL-1Ra</i> were investigated in relation to clinical...

Full description

Bibliographic Details
Main Authors: Martina Wahlund, Malin Lindqvist Appell, Ida Hed Myrberg, Anna Berggren, Anna Nilsson
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/7/12/296
_version_ 1797544466122276864
author Martina Wahlund
Malin Lindqvist Appell
Ida Hed Myrberg
Anna Berggren
Anna Nilsson
author_facet Martina Wahlund
Malin Lindqvist Appell
Ida Hed Myrberg
Anna Berggren
Anna Nilsson
author_sort Martina Wahlund
collection DOAJ
description Sequence variants in genes involved in the immune system have previously been linked to neutropenia as well as infections in cancer patients. Sequence variants in genes coding for <i>TLR4</i>, <i>MBL</i>, and <i>IL-1Ra</i> were investigated in relation to clinical utility of identifying severe episodes of febrile neutropenia (FN) in a cohort of children undergoing treatment for acute lymphoblastic leukemia. The study included 122 children, where data on FN and microbiological findings were retrospectively collected from medical records. Sequence variants in genes coding for <i>MBL</i>, <i>TLR4</i>, and <i>IL-1Ra</i> were identified by pyrosequencing, TaqMan SNP genotyping assay, and gel electrophoresis. A total of 380 episodes of FN were identified and in 139 episodes, there was a microbiological defined infection. Age and treatment intensity were all associated with the risk of developing FN. No sequence variant was associated to increased numbers of FN episodes. Two sequence variants in the <i>TLR4</i> gene increased the risk of viral infection, whilst sequence variants in the <i>IL-1Ra</i> gene were associated to a decreased risk of bacterial blood-stream infection (BSI). The investigated sequence variants did not associate with increased risk for FN or to severe infections, as to why the clinical utility as a risk-stratification tool is low. Most episodes of FN were classified as fever with unknown origin, emphasizing the need for improved microbial detection methods.
first_indexed 2024-03-10T14:00:55Z
format Article
id doaj.art-460ea7f90fe9474abbfe79b3638aa233
institution Directory Open Access Journal
issn 2227-9067
language English
last_indexed 2024-03-10T14:00:55Z
publishDate 2020-12-01
publisher MDPI AG
record_format Article
series Children
spelling doaj.art-460ea7f90fe9474abbfe79b3638aa2332023-11-21T01:07:35ZengMDPI AGChildren2227-90672020-12-0171229610.3390/children7120296Genetic Sequence Variants in <i>TLR4</i>, <i>MBL</i> or <i>IL-1</i> Receptor Antagonist is not Associated to Increased Risk for Febrile Neutropenia in Children with ALLMartina Wahlund0Malin Lindqvist Appell1Ida Hed Myrberg2Anna Berggren3Anna Nilsson4Department of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, 171 64 Stockholm, SwedenDepartment of Medical and Health Sciences, Division of Drug Research, Linkoping University, 581 83 Linkoping, SwedenChildhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, 171 65 Stockholm, SwedenDepartment of Medicine Solna, Division of Infectious Diseases, Karolinska Institutet, 171 64 Stockholm, SwedenChildhood Cancer Research Unit, Department of Women’s and Children’s Health, Karolinska Institutet, 171 65 Stockholm, SwedenSequence variants in genes involved in the immune system have previously been linked to neutropenia as well as infections in cancer patients. Sequence variants in genes coding for <i>TLR4</i>, <i>MBL</i>, and <i>IL-1Ra</i> were investigated in relation to clinical utility of identifying severe episodes of febrile neutropenia (FN) in a cohort of children undergoing treatment for acute lymphoblastic leukemia. The study included 122 children, where data on FN and microbiological findings were retrospectively collected from medical records. Sequence variants in genes coding for <i>MBL</i>, <i>TLR4</i>, and <i>IL-1Ra</i> were identified by pyrosequencing, TaqMan SNP genotyping assay, and gel electrophoresis. A total of 380 episodes of FN were identified and in 139 episodes, there was a microbiological defined infection. Age and treatment intensity were all associated with the risk of developing FN. No sequence variant was associated to increased numbers of FN episodes. Two sequence variants in the <i>TLR4</i> gene increased the risk of viral infection, whilst sequence variants in the <i>IL-1Ra</i> gene were associated to a decreased risk of bacterial blood-stream infection (BSI). The investigated sequence variants did not associate with increased risk for FN or to severe infections, as to why the clinical utility as a risk-stratification tool is low. Most episodes of FN were classified as fever with unknown origin, emphasizing the need for improved microbial detection methods.https://www.mdpi.com/2227-9067/7/12/296febrile neutropeniaacute lymphoblastic leukemia<i>TLR4</i><i>MBL</i><i>IL-1Ra</i>
spellingShingle Martina Wahlund
Malin Lindqvist Appell
Ida Hed Myrberg
Anna Berggren
Anna Nilsson
Genetic Sequence Variants in <i>TLR4</i>, <i>MBL</i> or <i>IL-1</i> Receptor Antagonist is not Associated to Increased Risk for Febrile Neutropenia in Children with ALL
Children
febrile neutropenia
acute lymphoblastic leukemia
<i>TLR4</i>
<i>MBL</i>
<i>IL-1Ra</i>
title Genetic Sequence Variants in <i>TLR4</i>, <i>MBL</i> or <i>IL-1</i> Receptor Antagonist is not Associated to Increased Risk for Febrile Neutropenia in Children with ALL
title_full Genetic Sequence Variants in <i>TLR4</i>, <i>MBL</i> or <i>IL-1</i> Receptor Antagonist is not Associated to Increased Risk for Febrile Neutropenia in Children with ALL
title_fullStr Genetic Sequence Variants in <i>TLR4</i>, <i>MBL</i> or <i>IL-1</i> Receptor Antagonist is not Associated to Increased Risk for Febrile Neutropenia in Children with ALL
title_full_unstemmed Genetic Sequence Variants in <i>TLR4</i>, <i>MBL</i> or <i>IL-1</i> Receptor Antagonist is not Associated to Increased Risk for Febrile Neutropenia in Children with ALL
title_short Genetic Sequence Variants in <i>TLR4</i>, <i>MBL</i> or <i>IL-1</i> Receptor Antagonist is not Associated to Increased Risk for Febrile Neutropenia in Children with ALL
title_sort genetic sequence variants in i tlr4 i i mbl i or i il 1 i receptor antagonist is not associated to increased risk for febrile neutropenia in children with all
topic febrile neutropenia
acute lymphoblastic leukemia
<i>TLR4</i>
<i>MBL</i>
<i>IL-1Ra</i>
url https://www.mdpi.com/2227-9067/7/12/296
work_keys_str_mv AT martinawahlund geneticsequencevariantsinitlr4iimblioriil1ireceptorantagonistisnotassociatedtoincreasedriskforfebrileneutropeniainchildrenwithall
AT malinlindqvistappell geneticsequencevariantsinitlr4iimblioriil1ireceptorantagonistisnotassociatedtoincreasedriskforfebrileneutropeniainchildrenwithall
AT idahedmyrberg geneticsequencevariantsinitlr4iimblioriil1ireceptorantagonistisnotassociatedtoincreasedriskforfebrileneutropeniainchildrenwithall
AT annaberggren geneticsequencevariantsinitlr4iimblioriil1ireceptorantagonistisnotassociatedtoincreasedriskforfebrileneutropeniainchildrenwithall
AT annanilsson geneticsequencevariantsinitlr4iimblioriil1ireceptorantagonistisnotassociatedtoincreasedriskforfebrileneutropeniainchildrenwithall